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Letter to the editor 
Immune response in children with COVID-19 is characterized by lower levels of T cell 
activation than infected adults. 
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To the Editor. 
COVID-19 [1],[2] has broad spectrum of manifestations, ranging from mild respiratory 
illness to severe pneumonia resulting in multiorgan failure and death in adult population. In 
children the disease  has a mild course characterized by fever, cough, and diarrhea[2]–[4]. In 
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addition, the infection can often be asymptomatic in infants in their first year of life despite 
respiratory diseases such as cystic fibrosis[5],[6].  Despite the large number of children 
infected by SARS-Cov-2, little is known about their immune response. 
We describe 14 children (P1 to P9; age from 12 days to 15 years) who have been infected 
during the SARS-Cov-2 epidemics and have developed from mild to moderate clinical 
manifestations (Supplemental Table 1).  In order to evaluate the inflammatory response 
during SARS-Cov-2 infection, we measured the levels of chemokines, or cytokines which are 
produced during viral or bacterial infection and are important in the innate immune response 
[7].  CXCL10/IP10, CXCL9/MIG, CCL5/RANTES CCL2/MCP-1, and interleukin-8 
(CXCL8/IL-8) were measured on plasma of 14 children and 9 adults with COVID-19 
(Supplemental Table 1). We observed that levels of plasmatic CCL5/RANTES, were 
significantly higher in both children and adults with COVID-19 as compared to control 
subjects (Figure 1). While CXCL9/MIG were higher in adults with COVID-19 in comparison 
with control group (Figure 1). CXCL10/IP10, CCL2-MCP1, and CXCL8/IL-8 (data not 
shown) were detected at comparable levels in the three groups of subjects (Figure 1).  
Evaluation of T-cell subsets revealed CD8 lymphopenia in three children with COVID-19 
(P3, P6, P9). None of the adults with COVID19 showed CD4 or CD8 lymphopenia. 
CD4/CD8 ratio, distribution of naïve, central memory, effector memory, and terminally 
differentiated CD4 and CD8 cells were normal in children as compared to lymphocyte 
populations of age-matched subjects analyzed in recent years for unrelated conditions 
(Supplemental Tables 2 and 3). However, comparison of terminally differentiated CD8 cells  
between children and adults infected with SARS-COV-2 showed a significantly higher 
number of this subset in adults subjects (data not shown). To investigate whether T detected 
in children with COVID-19 was related to impaired lymphocyte generation from thymus and 
bone marrow, respectively, we measured T-cell receptor excision circles (TRECs) and, which 
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are considered biomarkers for adequate new T- production. We observed that the levels of 
TRECs were within the range of age-matched control subjects in all children with COVID-19 
(data not shown), suggesting that decrease in lymphocyte counts were probably related to 
lymphocyte apoptosis or to migration of these cells to affected organs such as the lungs.   
Then, we evaluated the expression of the T-cell activation marker HLA-DR in COVID-19 
children and adults as compared to respective age-matched control groups. We found that the 
percentage of CD4 and CD8 subsets expressing HLA-DR was significantly higher in the 
adults as compared to control subjects, but not in children (Figure 2, panels A). Additional 
analyses of HLA-DR expression by CD4 and CD8 T cells in subjects with dyspnea, including 
adults (median CD4
+
/HLA-DR
+
: 7.2%; median CD8
+
/HLA-DR
+
:  17.4%) and children 
(median CD4
+
/HLA-DR
+
: 1.2%; median CD8
+
/HLA-DR
+
:  4.2%), did not show higher 
activation levels in adults with more severe clinical manifestation as compared with adults 
(median CD4
+
/HLA-DR
+
: 7.1%; median CD8
+
/HLA-DR
+
:  14.4%) or children (median 
CD4
+
/HLA-DR
+
: 1.5%; median CD8
+
/HLA-DR
+
:  1.3%) without dyspnea.  
 Next, we measured plasmatic levels of cytokines released during inflammatory or immune 
response including interferon-α (IFN-α), interferon-γ (IFN-γ), IL-1β, IL-4, IL-5, IL-6, IL-10, 
IL-12 (p70), IL-17A, and tumor necrosis factor-α (TNF-α). Remarkably, IL-12 (p70) and IL-
1β were significantly higher in plasma of COVID-19 children as compared with adults 
(Figure 2B). Likewise, IL-6, IL-10 and IL-5 concentrations were higher in plasma of adults 
with COVID-19,  while IFN-α was increased in children, but these differences were not 
statistically significant (data not shown). Concentrations of IL-4, IL-17A were below 
detection levels in both groups of patients (data not shown).  
It is remarkable, that lymphopenia was associated with reduction of CD8 cell counts in some 
patients, while CD4 counts were normal in all subjects, suggesting that CD8 might be 
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mobilized to lymphoid organs or to the lungs. While adults with COVID-19, especially 
severe cases can display persistent lymphopenia[8].  
Detection of elevated plasmatic levels of CCL5/RANTES at the early stages of SARS-Cov-2 
infection suggests its potential role in mobilizing T lymphocytes and monocytes to 
pulmonary tissues where this chemokine are produced at large amounts. CCL5/RANTES 
mediates recruitment of T lymphocytes and monocytes; it has also been implicated in arterial 
injury and in sustaining CD8 T-cell responses during a viral infection[9]. CCL5/RANTES is 
produced in large amounts by platelets and activated T cells but it is also expressed by 
respiratory epithelial cells and has been detected in the lungs of patients with SARS-COV-2 
infection [7]..   
HLA-DR expression on CD4 and CD8 cells was lower in children than in adults with 
COVID-19 at the time of hospital admission. One might speculate that activated T cells 
expressing chemokine receptors for CCL5/RANTES are not detected in peripheral blood 
because these cells were already mobilized to tissues or that innate immune response might 
be more effective in children. This is consistent with a recent report describing a moderate 
increase of CD8+ cells coexpressing HLA-DR and CD38 during COVID-19 recovery in one 
adult patient [10]. Alternatively,  SARS-CoV2 viral load might be more elevated in adult 
subjects as compared to children resulting in stronger T cell activation. In addition, we 
detected higher levels of IL-12 (p70) and of CXCL9/MIG in adults with COVID-19 
suggesting that prolonged T cell activation in adults with COVID-19 might result in Th1 
polarization and possibly in pulmonary tissue damage by activated T cells.  
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Figure legends 
Figure 1.  Chemokines and cytokines evaluation in children and adults affected by COVID-
19.  Plasmatic levels of CXCL10/IP10, CXCL9/MIG, CCL5/RANTES,  and CCL2/MCP-1 in 
14 children, 10 adults with COVID-19 were measured by Bead Array flow cytometry assay 
on  a single plasma sample at the time of hospital admission,  and 10 children with other 
infections are shown as median ± semi-interquartile range (pg/ml).  Kruskal-Wallis 
comparison test was used to compare values between healthy control subjects, COVID-19 
children and adults for analysis of CXCL10/IP10 (NS), CXCL9/MIG (P=0.0055), 
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CCL5/RANTES (P=0.0047),  and CCL2/MCP-1 (NS). When the test was statistically 
significant between three groups, Dunn’s multiple comparison test was used for pairwise 
differences between control group and COVID-19 children or adults. This was analysis 
showed significant difference in CXCL9 levels in between COVID-19 adults and control 
subjects (P<0.05), in CCL5 levels between COVID-19 adults and control subjects (P<0.05) 
and between COVID-19 and control subjects . Non significant (NS) when P>0.05.  
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Figure 2  Activation marker expression by T cells in COVID-19 patients. A: Expression of  
HLA-DR
+ 
(%) in CD4 (left panel) and CD8 (right panel) cells in children and adults with 
COVID-19  as compared to respective control subjects and analyzed by flow cytometry. Data 
are shown as median ±semi-interquartile range (% of cells). HLA-DR expression was 
measured on  a single blood sample collected at the time of hospital admission.  Kruskal-
Wallis comparison test was used to compare between healthy control subjects, COVID-19 
children and adults values of CD4
+
/HLA-DR
+
 cells (p<0.0001) and of CD8
+
/HLA-DR
+
 cells 
(P<0.0001). When the test was statistically significant between three groups, Dunn’s multiple 
comparison test was used for pairwise differences of CD4
+
/HLA-DR
+
 and CD8
+
/HLA-DR
+
 
cells between control group and COVID-19 children or adults. This analysis showed a 
significant difference in the values of CD4
+
/HLA-DR
+
 and of CD8
+
/HLA-DR
+
 in COVID-19 
adults as compared to control subjects (P<0.005).  B:  Cytokines evaluation in children and 
adults affected by COVID-19.  Plasmatic levels of IL-1beta, IL-12 (p70) in 14 children and 
10 adults with COVID-19 were measured by Bead Array flow cytometry assay on a single 
plasma sample at the time of hospital admission. Data are shown as mean ± standard 
deviation (pg/ml). Mann-Whitney comparison test showed significant differences of IL-1 
and IL-12 values between COVID-19 children and adults (P<0.05). 
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Study of immunological features of immune response in 14 children (aged from 12 days up to 
15 years) and of 10 adults who developed COVID-19 show increased number of activated 
CD4 and CD8 cells expressing DR and higher plasmatic levels of IL-12 and IL-1 in adults 
with COVID-19, but not in children. In addition, plasmatic levels of CCL5/RANTES  are 
higher in children and adults with COVID-19, while CXCL9/MIG was only increased in 
adults suggesting. Higher number of  activated T cells  and expression of IL-12 and CXCL9 
suggest prominent Th1 polarization of immune response against SARS-CoV2 in infected 
adults as compared with children. 
 
 
 
